Found 706 clinical trials

A Randomized Double Blind Placebo Controlled Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy

20.0

99 years and younger

All

Phase 3

Phase III Study of PET-Directed Local or Systemic Therapy Intensification in Prostate Cancer Patients with Post-Prostatectomy Biochemical Recurrence

TBD

99 years and younger

All

Phase 0

EMPACT-MI: A streamlined multicentre randomised parallel group double-blind placebo-controlled superiority trial to evaluate the effect of Empagliflozin on hospitalisation for heart failure and mortality in patients with aCuTe Myocardial Infarction

TBD

99 years and younger

All

Phase 0

Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

30.0

99 years and younger

All

UPCC 03621: A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B (Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

TBD

99 years and younger

All

Phase 0

EA5191 A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated NonSquamous NSCLC

TBD

99 years and younger

All

Phase 0

An Expanded Access Program for Efgartigimod Treatment in Patients With Generalized Myasthenia Gravis

1.0

99 years and younger

All

An open label single arm study of the safety pharmacokinetics and antiretroviral activity of the combination of 3BNC117-LS and 10-1074-LS in viremic HIV-infected individuals

TBD

99 years and younger

All

Phase 0

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)

TBD

99 years and younger

All

Phase 0

UPCC 02521 A Randomized Phase II Trial of Cabozantinib Combined with PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

0.0

99 years and younger

All

Phase 2

Found 706 clinical trials

A Randomized Double Blind Placebo Controlled Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy

Phase III Study of PET-Directed Local or Systemic Therapy Intensification in Prostate Cancer Patients with Post-Prostatectomy Biochemical Recurrence

EMPACT-MI: A streamlined multicentre randomised parallel group double-blind placebo-controlled superiority trial to evaluate the effect of Empagliflozin on hospitalisation for heart failure and mortality in patients with aCuTe Myocardial Infarction

Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

EA5191 A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated NonSquamous NSCLC

An Expanded Access Program for Efgartigimod Treatment in Patients With Generalized Myasthenia Gravis

An open label single arm study of the safety pharmacokinetics and antiretroviral activity of the combination of 3BNC117-LS and 10-1074-LS in viremic HIV-infected individuals

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)

UPCC 02521 A Randomized Phase II Trial of Cabozantinib Combined with PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

One platform. Various ways to connect patients to your clinical studies.

Contact Us

About Us

Our Solutions

For Industry

For Patients

Resources